Literature DB >> 9873955

Beneficial effect of octreotide treatment in acute pancreatitis in rats.

J Marton1, Z Szasz, Z Nagy, K Jarmay, T Takacs, J Lonovics, A Balogh, G Farkas.   

Abstract

CONCLUSIONS: Octreotide treatment contributes to the regulation of tumor necrosis factor (TNF) production in sodium taurocholate-induced acute necrotizing pancreatitis in rats. Owing to its complex effect, octreotide can partially ameliorate the deleterious consequences of acute necrotizing pancreatitis. Elevated TNF and interleukin-6 (IL-6) levels in the peritoneal fluid may be considered a consequence of the activation of peritoneal macrophages.
BACKGROUND: The effects of octreotide on exocrine pancreatic function have been investigated in numerous studies, but little attention has been paid to its influence on cytokine production in acute pancreatitis.
METHODS: Acute pancreatitis was induced by the retrograde injection of taurocholic acid into the pancreatic duct in male Wistar rats. Serum amylase activity, wet pancreatic weight/body weight (pw/bw) ratio, and TNF and IL-6 levels were measured. Four micrograms/kg of octreotide was administered subcutaneously at the time of induction of pancreatitis and 24 or 48 h later. Rats were sacrificed 6, 24, 48, or 72 h after the operation.
RESULTS: The serum amylase level and pancreatic weight to body weight ratio were decreased significantly in the octreotide-treated group. The serum TNF level was decreased significantly in the octreotide-treated group as compared with the control group at 6, 24, and 48 h (0.6 +/- 1.5, 2.0 +/- 3.3, and 0 vs 50 +/- 15.5, 37.5 +/- 18.4, and 13.1 +/- 12.5 U/mL, respectively). The ascites TNF level was decreased to 0 in the octreotide-treated group and was elevated in the control group at 72 h (28.0 +/- 49.0 U/mL). IL-6 production in ascites was extremely high in both groups at 6 h (80,000 +/- 43,817 pg/mL and 58,500 +/- 33,335 pg/mL), but the difference was not significant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873955     DOI: 10.1007/BF02788423

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  27 in total

1.  Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop.

Authors:  P De Rai; C Franciosi; G M Confalonieri; R Biffi; B Andreoni; F Uggeri; A Malesci
Journal:  Int J Pancreatol       Date:  1988-07

2.  Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.

Authors:  J M Bordas; V Toledo; F Mondelo; J Rodés
Journal:  Horm Res       Date:  1988

3.  Peritoneal and systemic cytokine response to laparotomy.

Authors:  J M Badia; S A Whawell; D M Scott-Coombes; P D Abel; R C Williamson; J N Thompson
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

4.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

5.  A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions.

Authors:  M Ceska; K Birath; B Brown
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

6.  A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat.

Authors:  Z H Zhu; S Holt; M S el-Lbishi; T Grady; T V Taylor; R E Powers
Journal:  Pancreas       Date:  1991-09       Impact factor: 3.327

7.  The effect of somatostatin, gabexate mesilate and dextran 40 on the microcirculation in sodium taurocholate-induced pancreatitis.

Authors:  K Kusterer; M Enghofer; T Poschmann; K H Usadel
Journal:  Acta Physiol Hung       Date:  1992

8.  The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats.

Authors:  Z Tulassay; K Kisfalvi; M Papp
Journal:  Z Gastroenterol       Date:  1995-02       Impact factor: 2.000

9.  Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.

Authors:  H Paran; J Klausner; A Siegal; E Graff; U Freund; O Kaplan
Journal:  J Surg Res       Date:  1996-05       Impact factor: 2.192

10.  Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany.

Authors:  H Fiess; I Klempa; P Hermanek; U Sulkowski; W Uhl; H G Beger; M W Büchler
Journal:  Digestion       Date:  1994       Impact factor: 3.216

View more
  2 in total

1.  Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Savio G Barreto; Colin J Carati; Ann C Schloithe; James Toouli; Gino T P Saccone
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

2.  Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Ozlem Ozer Cakir; Hasan Esen; Aysun Toker; Huseyin Ataseven; Ali Demir; Hakki Polat
Journal:  Int J Clin Exp Med       Date:  2015-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.